Literature DB >> 20827704

Sulfur ylide promoted synthesis of N-protected aziridines: a combined experimental and computational approach.

Irena Dokli1, Ivana Matanović, Zdenko Hameršak.   

Abstract

A range of N-protected aziridines [N-Tosyl (N-Ts), N-2-trimethylsilylethanesulfonamide (N-SES), N-tert-butoxycarbonylamido (N-Boc), and N-o-nitrobenzenesulfonamide (oNs)] were prepared in moderate to good yield and with high enantiomeric excess of both isomers starting from N-protected imines, using a sulfonium salt derived from Eliel's oxathiane. The diastereoselectivities of the reactions are influenced by the imine N-protecting group, the imine substituent, and the sulfide structure. An unusual cis selectivity was observed in the formation of N-tosyl-2-phenyl-3-tert-butylaziridine and N-o-trimethylsilylethanesulfonamide-2-phenyl-3-tert-butylaziridine, which was explained by using computational models. The analysis suggests that betaine formation in the case of N-tosyl-tert-butylaldimine aziridination using oxathiane benzyl sulfonium ylide 1' is reversible and that the selectivity is determined at the rotation step, which is unusual for semistabilized ylide aziridination. We have shown herein that the steric bulk of an imine substituent, in combination with a sterically demanding sulfonium ylide, can also affect the reversibility of the reaction. This is the first example of this sort involving aziridinations using semistabilized ylides.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2010        PMID: 20827704     DOI: 10.1002/chem.201001436

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Direct Stereodivergent Olefination of Carbonyl Compounds with Sulfur Ylides.

Authors:  Jérémy Merad; Phillip S Grant; Tobias Stopka; Juliette Sabbatani; Ricardo Meyrelles; Alexander Preinfalk; Ján Matyasovsky; Boris Maryasin; Leticia González; Nuno Maulide
Journal:  J Am Chem Soc       Date:  2022-06-30       Impact factor: 16.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.